Atlas Trials

Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies

Clinical trial NCT01744912 · TERMINATED

Trial details

NCT number
NCT01744912
Sponsor
TG Therapeutics, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Hodgkins LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaB-cell LymphomasMarginal Zone LymphomaMantle Cell LymphomaWaldenstrom's Macroglobulinemia
Start date
2012-11-21
Primary completion
2014-02-07
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.